Suchergebnisse - "Peng, Hui"

PubPharm (3.810)

21

Eco-friendly preparation and characterization of high-performance electrothermal graphene-AgNPs/lignocellulose composites

enthalten in: RSC advances | 2024

von Liu, F. | Yu, C. | Guo, X. | +2

22

Long-term trends in Alzheimer’s disease and other dementias deaths with high body mass index in China from 1990 to 2019, and projections up to 2042

enthalten in: Archives of public health | 2024

von Tao, M. | Guo, H. | Ji, X. | +3

23

Restoration of the Mucosal IgA Response by Improving CD4+ T Pyroptosis Fails to Attenuate Gut Bacterial Translocation and Organ Damage After LPS Attack

enthalten in: Digestive diseases and sciences | 2024

von Liu, Z. | Zhang, Y. | Zhang, H. | +3

24

Effective substances and molecular mechanisms guided by network pharmacology : An example study of Scrophulariae Radix treatment of hyperthyroidism and thyroid hormone-induced liver and kidney injuries

enthalten in: Journal of ethnopharmacology | 2024

von Sheng, M. | Peng, D. | Peng, H. | +11

25

Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligands

enthalten in: Nature communications | 2024

von Liu, J. | Malekoltojari, A. | Asokakumar, A. | +16

26

Identification and Biological Evaluation of a Novel Small-Molecule Inhibitor of Ricin Toxin

enthalten in: Molecules (Basel, Switzerland) | 2024

von Yang, X. | Wei, A. | Cao, X. | +4

27

Structural insights into curdlan degradation via a glycoside hydrolase containing a disruptive carbohydrate-binding module

enthalten in: Biotechnology for biofuels and bioproducts | 2024

von Lv, T. | Feng, J. | Jia, X. | +6

28

Structural insights into curdlan degradation via a glycoside hydrolase containing a disruptive carbohydrate-binding module

enthalten in: Biotechnology for biofuels and bioproducts | 2024

von Lv, T. | Feng, J. | Jia, X. | +6

29

Title High Solar-Thermal Conversion Aerogel for Efficient Atmospheric Water Harvesting

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2024

von Wang, X. | Ma, G. | Cui, S. | +3

30

Analysis of East Asia subgroup in Study 309/KEYNOTE-775 : lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

enthalten in: Journal of gynecologic oncology | 2024

von Yonemori, K. | Fujiwara, K. | Hasegawa, K. | +17